Can microRNAs be Biomarkers or Targets for Therapy of Ischemic Coronary Artery Disease in Metabolic Syndrome?

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|18|15|1722-1732

ISSN： 1389-4501

Source： Current Drug Targets, Vol.18, Iss.15, 2017-10, pp. : 1722-1732

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNAs in Peripheral Artery Disease

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 13, 2013-07 ,pp. : 1589-1595

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs Determining Inflammation as Novel Biomarkers and Potential Therapeutic Targets

By  

Current Medicinal Chemistry, Vol. 22, Iss. 22, 2015-08 ,pp. : 2666-2679

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs as Early Biomarkers in Obesity and Related Metabolic and Cardiovascular Diseases

By  

Current Pharmaceutical Design, Vol. 19, Iss. 32, 2013-10 ,pp. : 5704-5717

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs: Biomarkers for Cardiovascular Disease in Patients with Diabetes Mellitus

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 13, 2013-07 ,pp. : 1533-1539

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs as therapeutic targets and their potential applications in cancer therapy

By Cho William CS  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 8, 2012-08 ,pp. : 747-759

Informa Healthcare

Access to resources Recommend Favorite